bmiMD GLP-1 Telehealth (Semaglutide / Tirzepatide) vs Maximus Health Performance Protocol Membership
Specs, prices, editor verdict, and who should buy which - compared side-by-side.
bmiMD GLP-1 Telehealth (Semaglutide / Tirzepatide) (mid, $289–$499/mo) vs Maximus Health Performance Protocol Membership (premium, $89–$299/mo) - different tools for different jobs (see the per-product details below).
Compared on 0 shared specs · cross-category comparison (ai software vs diagnostic).
These are close picks. Both score in the same range. The right call depends on buyer profile - read the per-buyer recommendations below.
Who should buy which
Buyers ready for GLP-1 medical intervention who want telehealth access at meaningfully lower cost than retail Wegovy / Mounjaro, with included physician oversight and titration support.
You're unsure GLP-1 is the right intervention - start with diet + exercise + lab work first. Or you have insurance coverage for retail Wegovy / Mounjaro (run those through insurance instead).
Men 28-45 prioritizing fertility preservation (enclomiphene), buyers who want hormone + GLP-1 protocols bundled, and the audience that responds to performance/optimization brand positioning.
You find the brand voice off-putting (Marek lands cleaner clinically), you need complex multi-drug TRT stacks (Marek goes deeper), or you only want basic monitored TRT (Hone is cheaper).